Ceridian HCM Holding Inc.

NYSE:CDAY

69.52 (USD) • At close January 31, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 481.8465.2440423.3431.5399.7377.5365.9370.6336.1315.6301.2293.3282.1257.2250.4234.5222.8204.4192.6222.7221.8202.3196.3203.7200.3179.6179.3208.9262.3163.5157.5187108.4169.9
Cost of Revenue 0246.6238.7236.5226.1229.9217210210.3201196.6185.2190.2178.2164.1158.3141.3137.3127.7114122.2124113.5108.3110.1108.8104.6106.5119.7154.1102.299.8113.260.7110.7
Gross Profit 0218.6201.3186.8205.4169.8160.5155.9160.3135.1119116103.1103.993.192.193.285.576.778.6100.597.888.88893.691.57572.889.2108.261.357.773.847.759.2
Gross Profit Ratio 00.470.4580.4410.4760.4250.4250.4260.4330.4020.3770.3850.3520.3680.3620.3680.3970.3840.3750.4080.4510.4410.4390.4480.4590.4570.4180.4060.4270.4130.3750.3660.3950.440.348
Reseach & Development Expenses 59.35755.458.353.100000000000000000000000004.40026.30
General & Administrative Expenses 71.196.694.189.685.758.30067.70000000074.6074.60000000001.900.50.426.20
Selling & Marketing Expenses 86.893.586.483.17972.70054.20000000032.8000000000005.6051.350.21.50
SG&A 157.9190.1180.5172.7164.7131134126.5121.9131.8122.7122.5122101.3109.1111.895.6107.477.374.674.278.182.369.366.270.459.484.154.757.652.451.850.627.761.8
Other Expenses 000005.60-0.70-130.1-44.800-2.70000000-0.9000000027.5-0.651100
Operating Expenses 217.2247.1235.9231217.8187.4134126.5121.9147.5122.7122.5122118109.1111.895.6118.577.374.674.289.882.369.366.275.359.784.162.585.156.256.861.643.971.7
Operating Income 3128.520.814.140.738.826.529.438.43.32.4-6.5-18.6-8-16-19.7-2.4-21.9-0.6426.319.76.518.727.421.515.3-11.326.423.15.10.912.28.8-8.8
Operating Income Ratio 0.0640.0610.0470.0330.0940.0970.070.080.1040.010.008-0.022-0.063-0.028-0.062-0.079-0.01-0.098-0.0030.0210.1180.0890.0320.0950.1350.1070.085-0.0630.1260.0880.0310.0060.0650.081-0.052
Total Other Income Expenses Net -11.9-27.6-2.50-22.3-3.3-14-9.8-10-5.8-19.4-12.5-5.8-2.5-13.4-18.1-10.2-5.7-5.7-6.9-9.5-8.1-9.4-10-10.5-8.8-8.8-43.4-22.2-29.2-21.9-22-21.4-26.9-25.5
Income Before Tax 19.10.918.3018.435.512.519.628.4-2.5-17-19-24.4-10.5-29.4-37.8-12.6-27.6-6.3-2.916.811.6-2.98.716.912.76.5-54.74.2-6.1-16.8-21.1-9.2-18.1-34.3
Income Before Tax Ratio 0.040.0020.04200.0430.0890.0330.0540.077-0.007-0.054-0.063-0.083-0.037-0.114-0.151-0.054-0.124-0.031-0.0150.0750.052-0.0140.0440.0830.0630.036-0.3050.02-0.023-0.103-0.134-0.049-0.167-0.202
Income Tax Expense 4.2-9.916.31.811.3-10.116.316.518.52.740.83-1-8.5-126.6-10.3-5.5-8.48.213.1-65.62.45.72.1-0.91.16.8-48.50.91.911.27.3
Net Income 14.910.82-1.87.145.6-3.83.19.9-5.2-21-19.8-27.4-9.5-20.9-25.8-19.2-17.3-0.85.58.6-1.562.76.311.2-0.24.4-65.5-2.145-20.1-22.9-11.2-30.2-42.2
Net Income Ratio 0.0310.0230.005-0.0040.0160.114-0.010.0080.027-0.015-0.067-0.066-0.093-0.034-0.081-0.103-0.082-0.078-0.0040.0290.039-0.0070.310.0320.055-0.0010.024-0.365-0.010.172-0.123-0.145-0.06-0.279-0.248
EPS 0.090.070.01-0.010.050.29-0.0240.020.06-0.03-0.14-0.13-0.18-0.063-0.14-0.17-0.13-0.12-0.0050.0380.06-0.010.440.0450.08-0.0010.032-0.58-0.0160.69-0.31-0.35-0.17-0.460
EPS Diluted 0.090.070.01-0.010.040.29-0.0240.020.06-0.034-0.14-0.13-0.18-0.063-0.14-0.17-0.13-0.12-0.010.0360.057-0.010.420.040.076-0.0010.03-0.58-0.0160.69-0.15-0.17-0.17-0.470
EBITDA 80.930.147.930.450.292.860.15259.730.424.315.12.810.21.6-4.68-21.912.615.835.511.313.931.840.237.929.61.941.333.918.712.926.319.15.5
EBITDA Ratio 0.1680.0650.1090.0720.1160.2320.1590.1420.1610.090.0770.050.010.0360.006-0.0180.034-0.0980.0620.0820.1590.0510.0690.1620.1970.1890.1650.0110.1980.1290.1140.0820.1410.1760.032